Variability and evolution of Kaposi‚s sarcoma-associated herpesvirus in Europe and Africa
- 9 July 1999
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (10) , 1165-1176
- https://doi.org/10.1097/00002030-199907090-00004
Abstract
Objective: To study the evolution of Kaposi‚s sarcoma-associated herpesvirus (KSHV) or human herpesvirus type 8 in Europe and Africa. Design and methods: PCR and sequence analysis of the variable viral membrane glycoprotein gene K1 in 58 tumour and peripheral blood samples from patients with AIDS-related Kaposi‚s sarcoma (KS), ‚classic‚ (HIV-negative) KS, transplant KS, Multicentric Castleman‚s Disease, other lymphoproliferative disorders, and healthy KSHV-infected individuals from the UK, Denmark, Sweden, Italy, Spain, Iceland, The Faroe Islands, Greece, The Gambia and Uganda. Results: Three major groups of K1 sequences were found: A, B and C, as defined previously. The K1 gene has evolved, both within and between these three groups, under positive selection. KSHV group B strains predominate in Africa and are more distant from groups A and C, found in Europe, than A and C are from each other. Within group C two subgroups, C′ and C′′, can be identified. Subgroup C′′ is more closely related to group A in a region of the K1 protein and appears to be phylogenetically close to the branchpoint between A and C. Group A and C strains are currently found in both HIV-1-infected and -uninfected Europeans, and were already present in Europe before the start of the AIDS epidemic. We found some examples of closely related K1 sequences in Italy and Denmark, but in general KSHV strains in Europe did not cluster geographically. Conclusion: KSHV strains in East and West Africa are closely related but phylogenetically distant from those in Europe. The two major KSHV groups in Europe are more closely related, with some strains adopting an intermediate phylogenetic position. In Europe, KSHV strains may have been disseminated at least several decades ago. Variability in the K1 region is driven by selection and does not correlate with different KSHV-related pathologies or geographic regions where clinically more aggressive HIV-negative KS (‚endemic‚ KS) is more common.Keywords
This publication has 36 references indexed in Scilit:
- Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infectionsInternational Journal of Cancer, 1998
- Human Herpesvirus 8 Seroprevalence in Blood Donors and Lymphoma Patients From Different Regions of ItalyJNCI Journal of the National Cancer Institute, 1998
- Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigenThe Lancet, 1996
- Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patientsThe Lancet, 1996
- KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaNature Medicine, 1996
- The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmissionNature Medicine, 1996
- Seroconversion to Antibodies against Kaposi's Sarcoma–Associated Herpesvirus–Related Latent Nuclear Antigens before the Development of Kaposi's SarcomaNew England Journal of Medicine, 1996
- Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]Blood, 1995
- Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based LymphomasNew England Journal of Medicine, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994